Showing results (571-580 of 735) with videos related to
Sort By:
Pageof 74
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2017
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III TrialJames Larkin, David Minor, Sandra D'Angelo, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2021
Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapyAdriana Hepner, Victoria G Atkinson, James Larkin, et al.European Journal of Cancer Care|May 4, 2021
'This is not part of my life plan': A qualitative study on the psychosocial experiences and practical challenges in young adults with cancer age 25 to 39 years at diagnosisEmma Lidington, Carla Vlooswijk, Kate Stallard, et al.Gastroenterology|July 1, 2021
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation CohortsMichele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, et al.The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.Cell|May 20, 2026
Nociceptive innervation limits tertiary lymphoid structures to promote lung cancerYa-Hsuan Ho, Giacomo Bregni, Marco Stazi, et al.Plos Biology|January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasionHarriet V Mears, George R Young, Theo Sanderson, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Extrachromosomal DNA driven oncogene spatial heterogeneity and evolution in glioblastomaImran Noorani, Magnus Haughey, Jens Luebeck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.Pageof 74